Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Hydration Pharmaceuticals CoASX:HPC Equity-to-Asset is 0.65 as of Dec. 2025, which is 18% above its 10-year median of 0.55. The stock has 3 warning signs investors should review. Among 312 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 75.64% on this metric.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's Equity-to-Asset or its related term are showing as below:
ASX:HPC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05 Med: 0.55 Max: 0.83
Current: 0.65
During the past 5 years, the highest Equity to Asset Ratio of The Hydration Pharmaceuticals Co was 0.83. The lowest was -0.05. And the median was 0.55.
ASX:HPC's Equity-to-Asset is ranked better than 75.64% of 312
companies
in the Retail - Defensive industry
Industry Median: 0.44
vs ASX:HPC: 0.65
The Hydration Pharmaceuticals Co (ASX:HPC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
The Hydration Pharmaceuticals Co Equity-to-Asset Related Terms
The Hydration Pharmaceuticals Co Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Equity-to-Asset Chart
ASX:HPC vs SYY, USFD, PFGC: Equity-to-Asset Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Equity-to-Asset vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Equity-to-Asset falls into.
The Hydration Pharmaceuticals Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a Equity-to-Asset of 0.65 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on The Hydration Pharmaceuticals Co and its competitors. This is 18% above median its historical median of 0.55. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #76 out of 312 companies in the Retail - Defensive industry, placing it in the top 24.4%.
Is The Hydration Pharmaceuticals Co's Equity-to-Asset too high?
The Hydration Pharmaceuticals Co's current Equity-to-Asset of 0.65 is 18% above median its 10-year median of 0.55. The Retail - Defensive industry median Equity-to-Asset is 0.44. The Hydration Pharmaceuticals Co's value of 0.65 is 47.7% above this industry median. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #76 out of 312 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's Equity-to-Asset compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #76 out of 312 companies for Equity-to-Asset. This places The Hydration Pharmaceuticals Co in the top 24% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.44. The Hydration Pharmaceuticals Co's value of 0.65 is 47.7% above this benchmark. While the company's 10-year median is 0.55 vs. the industry median of 0.44, The Hydration Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Retail - Defensive company?
The median Equity-to-Asset among Retail - Defensive companies is 0.44, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Hydration Pharmaceuticals Co's current Equity-to-Asset of 0.65 is 47.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Equity-to-Asset is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Equity-to-Asset is 0.65, which is 18% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Equity-to-Asset of 0.65. The current Equity-to-Asset is 0.65, which is 18% above median its 10-year median of 0.55 and 47.7% above the Retail - Defensive industry median of 0.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Equity-to-Asset is 0.65 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
